Laxxon Medical | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Laxxon Medical

BRIEF

published on 02/04/2025 at 15:06, 10 months ago

Laxxon Medical Reports Promising Study Results for Parkinson's Treatment LXM.5

Bioavailability Laxxon Medical SPID®-Technology Parkinson's Treatment Levodopa/Carbidopa
PRESS RELEASE

published on 02/04/2025 at 15:01, 10 months ago

Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson’s Disease, LMX.5
Laxxon Medical announces positive pilot PK study results for advanced Levodopa/Carbidopa asset LMX.5, showcasing improved bioavailability and sustained levodopa levels, revolutionizing Parkinson's disease treatment

Parkinson's Disease Laxxon Medical PK Study Levodopa Carbidopa
BRIEF

published on 01/15/2025 at 15:20, 10 months 20 days ago

Laxxon Medical Reports Promising Results for Oral GLP-1 Dosage Form

Bioavailability SPID®-Technology GLP-1 Agonist Oral Drug Delivery Patient Compliance
PRESS RELEASE

published on 01/15/2025 at 15:15, 10 months 20 days ago

Laxxon Medical Announces Positive Pilot PK Study Results (in Pigs) for Groundbreaking Oral GLP-1 Dosage Form
Laxxon Medical announces successful pilot PK study results for innovative oral GLP-1 weight loss tablet LXM.2, achieving 10-fold bioavailability increase. SPID®-Technology enhances drug delivery and patient compliance

Drug Delivery Laxxon Medical SPID®-Technology Oral GLP-1 Weight Loss Tablet
BRIEF

published on 01/09/2025 at 15:05, 10 months 26 days ago

Laxxon Medical Adds Two New Members to Board of Directors

Financial Technology Business Development Board Appointment Digital Innovation Pharmaceutical Strategy
PRESS RELEASE

published on 01/09/2025 at 15:00, 10 months 26 days ago

Laxxon Medical Announces Appointment of Two New Members to Board of Directors
Laxxon Medical appoints Christof Bircher and Nneka Ukpai as new independent directors, bringing extensive experience to further the company's strategy and long-term shareholder value

Board Of Directors Pharmaceutical Industry Laxxon Medical Christof Bircher Nneka Ukpai
BRIEF

published on 01/07/2025 at 19:51, 10 months 28 days ago

Laxxon Medical to Attend 27th Annual Needham Growth Conference

Pharmaceuticals Investment Laxxon Medical SPID®-Technology Needham Growth Conference
PRESS RELEASE

published on 01/07/2025 at 19:46, 10 months 28 days ago

Laxxon Medical to Participate in 27th Annual Needham Growth Conference
Laxxon Medical to participate in the 27th Annual Needham Growth Conference with CEO/Chairman Helmut Kerschbaumer and CSO Alexander Ruckdaeschel meeting investors. Company specializes in smart drug delivery systems and advanced pharmaceuticals

Laxxon Medical Pharma-technology Advanced Pharmaceuticals Drug Delivery Systems Needham Growth Conference
BRIEF

published on 10/29/2024 at 16:15, 1 year 1 month ago

Laxxon Medical Appoints Lauren Chung as Chief Financial Officer

Chief Financial Officer Healthcare Industry Strategic Growth Laxxon Medical Lauren Chung
PRESS RELEASE

published on 10/29/2024 at 16:10, 1 year 1 month ago

Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer
Laxxon Medical appoints Lauren Chung PhD MBA as Chief Financial Officer, signaling strategic expansion. Dr. Chung brings over 2 decades of healthcare industry experience and will enhance financial and operational management capabilities

Chief Financial Officer Financial Management Healthcare Industry Laxxon Medical Lauren Chung

1 2 ... 4

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 50 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 55 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 25 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 20 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 25 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 55 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 34 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 10 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 15 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 25 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 40 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 41 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 24 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE